TYPE: Prescription
BRAND: Sitagliptin/Metformin hydrochloride Rowa
ACTIVE INGREDIENT: Sitagliptin/Metformin hydrochloride
STRENGTH, PACK SIZE & GMS CODE:
Sitagliptin/Metformin hydrochloride Rowa 50mg/850mg Film Coated Tablets x 56 (GMS 66990)Sitagliptin/Metformin hydrochloride Rowa 50mg/850mg Film Coated Tablets x 56 (GMS 66991)
INDICATION:
For adult patients with type 2 diabetes mellitus:Sitagliptin/Metformin hydrochloride Rowa is indicated as an adjunct to diet and exercise to improve glycaemic control in
patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the
combination of sitagliptin and metformin.
Sitagliptin/Metformin hydrochloride Rowa is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as
an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a
sulphonylurea.
Sitagliptin/Metformin hydrochloride Rowa is indicated as triple combination therapy with a peroxisome proliferator-activated
receptor gamma (PPAR g ) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled
on their maximal tolerated dose of metformin and a PPARg agonist.
Sitagliptin/Metformin hydrochloride Rowa is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct
to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide
adequate glycaemic control.
Sitagliptin/Metformin hydrochloride Rowa 50mg/850mg Film Coated Tablets SPC and PIL
Sitagliptin/Metformin hydrochloride Rowa 50mg/1000mg Film Coated Tablets SPC and PIL
